Edgewise Therapeutics to Present at the Stifel 2023 CNS Days on March 28, 2023

Author's Avatar
Mar 21, 2023

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating muscle disorders, today announced that management will present at the virtual Stifel 2023 CNS Days on Tuesday, March 28, 2023, at 2 pm ET.